bf/NASDAQ:RETA_icon.jpeg

NASDAQ:RETA

Reata Pharmaceuticals

  • Stock

USD

Last Close

172.32

25/09 20:00

Market Cap

6.57B

Beta: 1.53

Volume Today

1.91M

Avg: 1.45M

PE Ratio

−81.11

PFCF: −26.32

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
revenue
51.95M
-
50.32M
3.15%
49.86M
0.92%
48.06M
3.61%
53.59M
11.51%
26.52M
50.52%
9.02M
65.99%
11.49M
27.40%
2.22M
80.71%
cost of revenue
124.40M
-
gross profit
51.95M
-
50.32M
3.15%
49.86M
0.92%
48.06M
3.61%
53.59M
11.51%
-97.88M
282.65%
9.02M
109.21%
11.49M
27.40%
2.22M
80.71%
selling and marketing expenses
general and administrative expenses
11.51M
-
13.69M
18.95%
16.60M
21.25%
23.26M
40.10%
32.75M
40.79%
58.30M
78.02%
75.13M
28.87%
99.00M
31.78%
109.28M
10.38%
selling general and administrative expenses
11.51M
-
13.69M
18.95%
16.60M
21.25%
23.26M
40.10%
32.75M
40.79%
58.30M
78.02%
75.13M
28.87%
99.00M
31.78%
109.28M
10.38%
research and development expenses
34.30M
-
35.14M
2.44%
39.45M
12.27%
71.27M
80.65%
97.29M
36.50%
128.11M
31.68%
159.08M
24.18%
155.99M
1.94%
169.84M
8.88%
other expenses
2.51M
-
1.82M
27.59%
682K
62.51%
-3K
100.44%
431K
14,466.67%
932K
116.24%
1.14M
21.89%
1.20M
5.90%
1.13M
6.07%
cost and expenses
48.33M
-
50.65M
4.81%
56.74M
12.01%
94.97M
67.38%
130.47M
37.38%
311.74M
138.94%
235.34M
24.51%
256.20M
8.86%
280.25M
9.39%
operating expenses
48.33M
-
50.65M
4.81%
56.74M
12.01%
94.97M
67.38%
130.47M
37.38%
187.34M
43.59%
235.34M
25.62%
256.20M
8.86%
280.25M
9.39%
interest expense
1.45M
-
6.18M
324.76%
11.20M
81.30%
36.78M
228.47%
53.25M
44.79%
41.77M
21.56%
ebitda
6.09M
-
1.45M
76.16%
-6.41M
541.43%
-46.48M
624.63%
-76.45M
64.48%
-284.29M
271.88%
-225.19M
20.79%
-243.50M
8.13%
-269.02M
10.48%
operating income
3.63M
-
-334K
109.21%
-6.88M
1,960.48%
-46.91M
581.66%
-76.88M
63.88%
-285.22M
271.00%
-226.32M
20.65%
-244.71M
8.12%
-270.15M
10.40%
depreciation and amortization
2.51M
-
1.82M
27.59%
682K
62.51%
437K
35.92%
431K
1.37%
932K
116.24%
1.14M
21.89%
1.20M
5.90%
1.13M
6.07%
total other income expenses net
43K
-
32K
25.58%
214K
568.75%
698K
226.17%
2.53M
263.04%
-4.94M
295.03%
-43.91M
788.59%
-53.13M
20.98%
-41.77M
21.38%
income before tax
3.67M
-
-302K
108.23%
-6.67M
2,107.95%
-47.67M
614.88%
-80.52M
68.92%
-290.16M
260.36%
-270.24M
6.87%
-297.84M
10.21%
-311.93M
4.73%
income tax expense
2.98M
-
1.15M
61.46%
-441K
138.41%
3K
100.68%
26K
766.67%
8K
69.23%
-22.49M
281,187.50%
-450K
98.00%
-25K
94.44%
net income
689K
-
-1.45M
310.45%
-6.23M
329.45%
-47.67M
665.55%
-80.55M
68.96%
-290.17M
260.25%
-247.75M
14.62%
-297.39M
20.03%
-311.90M
4.88%
weighted average shs out
5.50M
-
5.50M
0%
19.82M
260.30%
23.93M
20.77%
27.70M
15.75%
30.41M
9.79%
33.71M
10.83%
36.32M
7.75%
36.32M
0%
weighted average shs out dil
20.00M
-
5.50M
72.50%
19.82M
260.30%
23.93M
20.77%
27.70M
15.75%
30.41M
9.79%
33.71M
10.83%
36.32M
7.75%
36.32M
0%
eps
0.13
-
-0.26
300%
-0.31
19.23%
-1.99
541.94%
-2.91
46.23%
-9.54
227.84%
-7.35
22.96%
-8.19
11.43%
-8.59
4.88%
epsdiluted
0.03
-
-0.26
853.62%
-0.31
19.23%
-1.99
541.94%
-2.91
46.23%
-9.54
227.84%
-7.35
22.96%
-8.19
11.43%
-8.59
4.88%

All numbers in USD (except ratios and percentages)